453 related articles for article (PubMed ID: 34008016)
21. Seroprevalence of SARS-CoV-2 Antibodies and Associated Factors in Health Care Workers.
Santosh CS; Tukaram DP; Maharudra K; Balkrishna A; Chinmay G; Aniket I; Kinge K; Nilam J
J Assoc Physicians India; 2021 Aug; 69(8):11-12. PubMed ID: 34472805
[TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2 Seroprevalence among the Health Care Staff of an Ophthalmological Reference Centre, a Cross Sectional Study.
Magaña-Guerrero FS; Trujillo DH; Buentello-Volante B; Aguayo-Flores JE; Melgoza-González EA; Hernández J; Jiménez-Martínez MC; Pérez-Tapia SM; Garfias Y
Ophthalmic Epidemiol; 2022 Oct; 29(5):483-490. PubMed ID: 34530684
[TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2 infections among healthcare workers at Helsinki University Hospital, Finland, spring 2020: Serosurvey, symptoms and risk factors.
Kantele A; Lääveri T; Kareinen L; Pakkanen SH; Blomgren K; Mero S; Patjas A; Virtanen J; Uusitalo R; Lappalainen M; Järvinen A; Kurkela S; Jääskeläinen AJ; Vapalahti O; Sironen T
Travel Med Infect Dis; 2021; 39():101949. PubMed ID: 33321195
[TBL] [Abstract][Full Text] [Related]
24. SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient's Referral in Tehran, Iran.
Darvishian M; Sharafkhah M; Mohammadi Z; Sadeghniiat-Haghighi K; Abdollahi A; Jafary M; Talaschian M; Tabarsi P; Baghai P; Mardani M; Shayanrad A; Shafighian F; Markarian M; Roozafzai F; Zamani M; Alvand S; Hariri S; Sadeghi A; Poustchi H; Malekzadeh R
Front Public Health; 2022; 10():832003. PubMed ID: 35400056
[TBL] [Abstract][Full Text] [Related]
25. Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.
Ladoire S; Rederstorff E; Goussot V; Parnalland S; Briot N; Ballot E; Truntzer C; Ayati S; Bengrine-Lefevre L; Bremaud N; Coudert B; Desmoulins I; Favier L; Fraisse C; Fumet JD; Hennequin A; Hervieu A; Ilie S; Kaderbhai C; Lagrange A; Martin N; Mazilu I; Mayeur D; Palmier R; Simonet-Lamm AL; Vincent J; Zanetta S; Arnould L; Coutant C; Bertaut A; Ghiringhelli F
Eur J Cancer; 2022 Apr; 165():13-24. PubMed ID: 35189537
[TBL] [Abstract][Full Text] [Related]
26. A cross-sectional study of SARS-CoV-2 seroprevalence among asymptomatic healthcare workers in a tertiary healthcare centre: Assessing the impact of PPE guidelines.
Wattal C; Oberoi JK; Goel N; Datta S; Raveendran R; Rao BK; Kumar R
Indian J Med Microbiol; 2021; 39(4):528-533. PubMed ID: 34688485
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust.
Hodgson D; Colton H; Hornsby H; Brown R; Mckenzie J; Bradley KL; James C; Lindsey BB; Birch S; Marsh L; Wood S; Bayley M; Dickson G; James DC; Nicklin MJH; Sayers JR; Zafred D; Rowland-Jones SL; Kudesia G; Kucharski A; ; Darton TC; de Silva TI; Collini PJ
medRxiv; 2021 Jul; ():. PubMed ID: 34268521
[TBL] [Abstract][Full Text] [Related]
28. Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area.
Alroqi F; Masuadi E; Alabdan L; Nogoud M; Aljedaie M; Abu-Jaffal AS; Barhoumi T; Almasoud A; Alharbi NK; Alsaedi A; Khan M; Arabi YM; Nasr A
J Infect Public Health; 2021 Sep; 14(9):1268-1273. PubMed ID: 34479078
[TBL] [Abstract][Full Text] [Related]
29. Seroprevalence of SARS-CoV-2 antibodies, associated epidemiological factors and antibody kinetics among healthcare workers in Connecticut.
Papasavas P; Olugbile S; Wu U; Robinson K; Roberts AL; O'Sullivan DM; McLaughlin T; Mather JF; Steinberg AC; Orlando R; Kumar A
J Hosp Infect; 2021 Aug; 114():117-125. PubMed ID: 33930487
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 RBD-specific and NP-specific antibody response of healthcare workers in the westernmost Austrian state Vorarlberg: a prospective cohort study.
Atzl M; Muendlein A; Winder T; Fraunberger P; Brandtner EM; Geiger K; Klausberger M; Duerkop M; Sprenger L; Mutschlechner B; Volgger A; Benda M; Severgnini L; Jaeger JB; Drexel H; Lang A; Leiherer A
BMJ Open; 2022 May; 12(5):e052130. PubMed ID: 35613821
[TBL] [Abstract][Full Text] [Related]
31. Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain.
Varona JF; Madurga R; Peñalver F; Abarca E; Almirall C; Cruz M; Ramos E; Castellano Vázquez JM
Int J Epidemiol; 2021 May; 50(2):400-409. PubMed ID: 33434269
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2 seroprevalence among 7950 healthcare workers in the Region of Southern Denmark.
von Huth S; Lillevang ST; Røge BT; Madsen JS; Mogensen CB; Coia JE; Möller S; Justesen US; Johansen IS
Int J Infect Dis; 2021 Nov; 112():96-102. PubMed ID: 34534698
[TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 seroprevalence in healthcare workers and risk factors.
Weber S; Didelot A; Agrinier N; Peyrin-Biroulet L; Schvoerer E; Rabaud C; Jeulin H
Infect Dis Health; 2022 Nov; 27(4):203-210. PubMed ID: 35644801
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19.
Esposito S; Neglia C; Affanni P; Colucci ME; Argentiero A; Veronesi L; Messina G; Deolmi M; Principi N;
Front Public Health; 2021; 9():628098. PubMed ID: 34249830
[No Abstract] [Full Text] [Related]
35. Seroprevalence of IgG against SARS-CoV-2 and its determinants among healthcare workers of a COVID-19 dedicated hospital of India.
Mahto M; Banerjee A; Biswas B; Kumar S; Agarwal N; Singh PK
Am J Blood Res; 2021; 11(1):44-52. PubMed ID: 33796388
[TBL] [Abstract][Full Text] [Related]
36. Risk of SARS-CoV-2 exposure among hospital healthcare workers in relation to patient contact and type of care.
Klevebro S; Bahram F; Elfström KM; Hellberg U; Hober S; Merid SK; Kull I; Nilsson P; Tornvall P; Wang G; Conneryd Lundgren K; Ponzer S; Dillner J; Melén E
Scand J Public Health; 2021 Nov; 49(7):707-712. PubMed ID: 34148454
[TBL] [Abstract][Full Text] [Related]
37. Seroprevalence of Covid-19 infection among healthcare workers: A study from a tertiary care hospital in the National Capital Region of India.
Kataria S; Phogat R; Sharma P; Deswal V; Alam S; Singh M; Kumar K; Gupta V; Singh P; Dutt R; Sarma S; Saxena R; Trehan N
Natl Med J India; 2022; 35(4):219-220. PubMed ID: 36715047
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 Incidence, signs and symptoms and main risk factors for COVID-19 infection in Health Care Workers: A hospital-wide survey in Salvador, Brazil.
Montaño-Castellón I; Lins-Kusterer L; Luz E; Pedroso C; Paz M; Brites C
Braz J Infect Dis; 2022; 26(4):102387. PubMed ID: 35905929
[TBL] [Abstract][Full Text] [Related]
39. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among hospital workers in a severely affected institution in Madrid, Spain: A surveillance cross-sectional study.
Pérez-García F; Pérez-Zapata A; Arcos N; De la Mata M; Ortiz M; Simón E; Hervás Fernández I; González Ventosa V; Muñoz Monte M; González Arroyo J; Pérez-Tanoira R; Cuadros-González J
Infect Control Hosp Epidemiol; 2021 Jul; 42(7):803-809. PubMed ID: 33118904
[TBL] [Abstract][Full Text] [Related]
40. The kinetics and predictors of anti-SARS-CoV-2 antibodies up to 8 months after symptomatic COVID-19: A Czech cross-sectional study.
Štěpánek L; Janošíková M; Štěpánek L; Nakládalová M; Boriková A
J Med Virol; 2022 Aug; 94(8):3731-3738. PubMed ID: 35419860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
